NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Zinc deficiency profoundly increases risk for HIV-1 related mortality.

Baum M, Shor-Posner G, Lai S, Lai H, Perez E, Page JB; International Conference on AIDS.

Int Conf AIDS. 1998; 12: 841 (abstract no. 42337).

University of Miami, FL, USA.

OBJECTIVE: Zinc is thought to promote activity of the HIV-1 virus. This trace element is, however, essential for maintaining a healthy immune system. As zinc deficiency is prevalent in HIV/AIDS, the aim of this study was to evaluate zinc status, disease progression and HIV-1 related mortality. DESIGN: A longitudinal study was conducted over 3.5 years in 118 HIV-1 seropositive men and women who abuse drugs. METHODS: Zinc intake was examined in relation to plasma zinc levels, CD4 cell count and HIV-related mortality. A multivariate Cox model, adjusted for age, sex, race and CD4 cell count over time was used to analyze the longitudinal data. RESULTS: Eighty-six percent of the HIV-1 infected drug users consumed dietary intake below the recommended dietary allowance and 56% of the group had plasma zinc levels considered deficient (< 0.75 microgram/ml). Plasma zinc levels were positively associated (p = 0.005) with CD4 cell count, and overtly low plasma zinc was associated (p = 0.002) with advanced disease (CD4 < 200 cells/mm3). While plasma zinc has been previously described as a marker of disease progression, those with higher intake of zinc over time, exhibited significantly higher levels of plasma zinc (p < 0.0001). In addition, low dietary zinc intake (below the median of 9.34 mg/day) was significantly associated with a dramatic risk for mortality (RH = 36.97, p < 0.03). CONCLUSIONS: The significant association between dietary and plasma zinc, and poor survival in HIV-1 infection indicates that adequate amounts of dietary zinc are needed to slow disease progression. Zinc therapy in HIV+ individuals who have overtly low plasma zinc levels needs to be investigated.

Publication Types:
  • Meeting Abstracts
Keywords:
  • Acquired Immunodeficiency Syndrome
  • CD4 Lymphocyte Count
  • Disease Progression
  • Female
  • HIV
  • HIV Infections
  • HIV Seropositivity
  • HIV-1
  • Humans
  • Longitudinal Studies
  • Male
  • Malnutrition
  • Nutritional Status
  • Proportional Hazards Models
  • Substance-Related Disorders
  • Vitamin A Deficiency
  • Zinc
  • mortality
Other ID:
  • 98404321
UI: 102231135

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov